Myxedema coma laboratory findings
Myxedema coma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Myxedema coma laboratory findings On the Web |
American Roentgen Ray Society Images of Myxedema coma laboratory findings |
Risk calculators and risk factors for Myxedema coma laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Laboratory Findings
Myxedematous coma should be considered in any patient who is comatose or who has some degree of deterioration of the sensorium with hypothermia or absence of fever in the presence of infection, hyponatremia and / or hypercapnia. Performing a thyroid routine test is considered best initial step in management of patients with myxedema coma.
- Serum TSH should be measured to distinguish hypothyroidism primary of the central.
- TSH might not be so as would be expected due to the presence of concomitant severe systemic disease which produces a low T3 syndrome (or syndrome of euthyroid), that in this scenario we could refer to it as "sick hypothyroid syndrome" .
- The use of certain drugs such as dopamine or glucocorticoids also decrease the levels of TSH.
- The levels of T4 and T3 (total and free fractions) they will always be low.
- In all cases measure cortisol and ACTH to evaluate or rule out the presence of primary adrenal insufficiency or secondary school.
- CBC shows Anemia, leucopenia, hyponatremia, increased lactic dehydrogenase (LDH), creatine phosphokinase (CPK) and transaminases, hypercholesterolemia, increased creatinine and hypoglycemia.
- Blood gases will reveal hypoxemia, hypercapnia and acidosis.